Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement

In patients receiving intracoronary stents, stent thrombosis is reduced when ticlopidine therapy is combined with aspirin after the procedure. However, ticlopidine causes neutropenia in 1% of patients when administered for >2 weeks, and little is known about the duration that ticlopidine needs be...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 1999-01, Vol.99 (2), p.248-253
Hauptverfasser:	BERGER, P. B, BELL, M. R, HASDAI, D, GRILL, D. E, MELBY, S, HOLMES, D. R
Format:	Artikel
Sprache:	eng
Schlagworte:	Abciximab Adult Aged Aged, 80 and over Antibodies, Monoclonal - pharmacology Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Coronary Disease - therapy Drug Administration Schedule Endosonography Enoxaparin - therapeutic use Female Humans Immunoglobulin Fab Fragments - pharmacology Male Medical sciences Middle Aged Myocardial Infarction - therapy Neutropenia - chemically induced Pharmacology. Drug treatments Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - pharmacology Prospective Studies Safety Stents - adverse effects Thrombosis - prevention & control Ticlopidine - administration & dosage Ticlopidine - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!